Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist’s impact on anticoagulant therapy

被引：0
|
作者：
Esin Aysel Kandemir
Aygin Bayraktar-Ekincioglu
Saadettin Kilickap
机构：
[1] Hacettepe University,Faculty of Pharmacy, Department of Clinical Pharmacy
[2] Hacettepe University,Hacettepe Cancer Institute
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Cancer; Venous thromboembolism; Practice guideline; Guideline adherence; Pharmacist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1699 / 1709
页数：10
相关论文
共 50 条
  • [1] Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist's impact on anticoagulant therapy
    Kandemir, Esin Aysel
    Bayraktar-Ekincioglu, Aygin
    Kilickap, Saadettin
    SUPPORTIVE CARE IN CANCER, 2021, 29 (03) : 1699 - 1709
  • [2] An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism
    Martins, Murillo A.
    Silva, Taysa F.
    Fernandes, Caio J.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (05) : 425 - 432
  • [3] An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism
    Murillo A. Martins
    Taysa F. Silva
    Caio J. Fernandes
    Current Oncology Reports, 2023, 25 : 425 - 432
  • [4] Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism after Cancer Remission
    Hara, Nobuhiro
    Lee, Tetsumin
    Mitsui, Kentaro
    Nagase, Masashi
    Okata, Shinichiro
    Nitta, Giich
    Kaneko, Masakazu
    Nagata, Yasutoshi
    Nozato, Toshihiro
    Ashikaga, Takashi
    ANNALS OF VASCULAR DISEASES, 2021, 14 (02) : 146 - 152
  • [5] Update: Anticoagulant Treatment of Cancer-associated Venous Thromboembolism
    Riess, Hanno
    AKTUELLE KARDIOLOGIE, 2022, 11 (02) : 131 - 135
  • [6] Update: Anticoagulant Treatment of Cancer-associated Venous Thromboembolism
    Riess, Hanno
    PHLEBOLOGIE, 2025, 54 (02) : 78 - 83
  • [7] Direct Oral Anticoagulant Therapy for Cancer-Associated Venous Thromboembolism in Routine Clinical Practice
    Ogino, Yutaka
    Ishigami, Tomoaki
    Minamimoto, Yugo
    Kimura, Yuichiro
    Akiyama, Eiichi
    Okada, Kozo
    Matsuzawa, Yasushi
    Maejima, Nobuhiko
    Iwahashi, Noriaki
    Hibi, Kiyoshi
    Kosuge, Masami
    Ebina, Toshiaki
    Ishikawa, Toshiyuki
    Tamura, Kouichi
    Kimura, Kazuo
    CIRCULATION JOURNAL, 2020, 84 (08) : 1330 - 1338
  • [8] Optimal anticoagulant treatment of cancer-associated venous thromboembolism remains unclear
    Al-Samkari, Hanny
    BMJ EVIDENCE-BASED MEDICINE, 2019, 24 (03) : 115 - 116
  • [9] Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer-associated venous thromboembolism
    Zakai, N. A.
    Walker, R. F.
    MacLehose, R. F.
    Adam, T. J.
    Alonso, A.
    Lutsey, P. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (12) : 2403 - 2412
  • [10] Risk assessment models for cancer-associated venous thromboembolism
    Dutia, Mrinal
    White, Richard H.
    Wun, Ted
    CANCER, 2012, 118 (14) : 3468 - 3476
12345